• FirefoxInstall the new Firefox »
  •  Dow Down 0.45% Nasdaq Down 0.49%

    Gilead Sciences Inc. (GILD)

    -NasdaqGS
    103.53 Down 0.66(0.63%) Feb 27, 4:00PM EST
    |After Hours : 103.48 Down 0.05 (0.05%) Feb 27, 7:58PM EST
    Add to Portfolio
    Prev Close:104.19
    Open:104.28
    Bid:N/A
    Ask:104.95 x 200
    1y Target Est:119.04
    Beta:0.83
    Earnings Date:Apr 20 - Apr 24 (Est.)
    Day's Range:102.71 - 104.34
    52wk Range:63.50 - 116.83
    Volume:7,939,977
    Avg Vol (3m):16,477,100
    Market Cap:155.19B
    P/E (ttm):14.09
    EPS (ttm):7.35
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for GILD

    Comparison

    Symbol% ChgMkt Cap
    GILDDown 0.63%155.19B
    GSKDown 0.88%114.07B
    PFEDown 0.78%216.24B
    RHHBYUp 0.80%191.83B

    Key Statistics

    Forward P/E (1 yr):9.99
    P/S (ttm):6.27
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :9.53
    Quarterly EPS Est (Mar-15) :2.26
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):0.43

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical nee in North America, South America, Europe, and the Asia-Pacific. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback